CardioExchange Archive

September 1st, 2014

New Support For Complete Revascularization During Primary PCI

Larry Husten, PHD

Until recently, MI patients receiving emergency PCI would only have the culprit artery opened. Complete revascularization of non-infarct-related arteries was performed later. The conventional wisdom was that revascularization of non-infarct-related arteries could be dangerous. That wisdom began to change last year with the PRAMI trial, which found no evidence of harm and a suggestion of benefit in […]

---

August 30th, 2014

ESC.14 Headquarters

wpengine

CardioExchange is dedicated to bringing you the latest from ESC.14. Check out our coverage of the conference here at CardioExchange and don’t forget to tell us what you think! News: PARADIGM-HF Establishes a New Paradigm for Heart Failure Treatment SIGNIFY Trial Provokes Sound and Fury Over Controversial Drug Preliminary Outcomes Results For PCSK9 Inhibitor New Support For […]

---

August 7th, 2014

Fellows: Want to Blog for CardioExchange at ESC.14?

Harlan M. Krumholz, MD, SM and John Ryan, MD

CardioExchange editors Harlan Krumholz and John Ryan are looking for fellows to blog for CardioExchange at the European Society of Cardiology Congresses from August 30th through September 3rd in Barcelona, Spain. If you are interested in blogging, please contact us. We look forward to hearing from you!

---

February 6th, 2014

Scrutinizing the ESC Position Paper on Radiation Safety in Cardiovascular Imaging

Reza Fazel, MD, MSc

Reza Fazel assesses the strengths, weaknesses, and implications of the ESC document.

---

January 28th, 2014

Problems Persist Despite Gains in Oral Anticoagulant Use

Larry Husten, PHD

Although significant progress has been made in recent years, a new survey from the European Society of Cardiology finds that there are still too many atrial fibrillation patients who are not taking the best medications to reduce their elevated risk for stroke. Many elderly patients are not receiving oral anticoagulants — either traditional warfarin or […]

---

January 21st, 2014

A Clinical Decision-Making Toolkit from Europe

Héctor Bueno, MD, PhD

Héctor Bueno introduces a new clinical decision-making toolkit, for non-experts and experts in training, developed by the Acute Cardiovascular Care Association of the European Society of Cardiology

---

September 4th, 2013

Something New, or the Same Again?

Paddy Barrett, MB BCh BAO MRCPI MCTI

What’s the value of the ESC Congress, wonders this Fellow. More than the cutting-edge science, it’s the way the Congress strengthens the unity among all of us in the community of cardiovascular disease, both at home and abroad.

---

September 4th, 2013

Same Disease, Different Tools

Amanda Ruth Vest, MBBS

The standard pharmacological heart-failure treatment may not have changed much in the U.S. recently, but this fellow discovers different approaches in Europe and some potential new drugs on the horizon.

---

September 3rd, 2013

Echo CRT Trial – Going Narrow Doesn’t Broaden CRT Population

Edward J. Schloss, MD

A once promising indication for cardiac resynchronization therapy (CRT) in selected heart failure patients with narrow QRS intervals has suffered a major blow with the premature termination of the Biotronik sponsored multicenter EchoCRT trial.

---

September 3rd, 2013

Renal Denervation: The Next Magic Bullet?

M. Louis Handoko, MD PhD

Hypertension, diabetes, acute and chronic heart failure, worsening of renal function, obstructive sleep apnea…. A CardioExchange Fellow reacts to a session on new potential indications for this treatment modality.

---